Back to News
Market Impact: 0.12
Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights
Source: PR Newswire
Legal & LitigationCompany Fundamentals
DJS Law Group highlighted an ongoing class action lawsuit against Capricor Therapeutics (NASDAQ: CAPR) alleging violations of the Securities Exchange Act sections 10(b) and 20(a) and Rule 10b-5. The note provides reminder-level information without new quantified financial or operational allegations. Overall, it modestly increases legal overhang risk for the shares.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.15
Ticker Sentiment
CAPR-0.90
More News
- Musk says Terrafab chip factory could outperform rivals despite challenges
- Will Warner Bros. kill Skydance — or will David Ellison kill Warner Bros?
- Last-Minute Lawsuit Upends Cable One’s $480 Million Mega Broadband Deal
- Nvidia GPUs are everywhere. Here are the ways companies are accessing them
- How U.S. know-how is fracking Australia into a gas boom, from Texas oilmen to Trump’s energy secretary
- Cerebras Is About as Big as Nvidia's Data Center Business Was Nearly a Decade Ago. The Similarities Mostly End There.
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AI Software for Buy-Side Teams: Build the Research Stack
- Augmented Intelligence: AllMind, Elevate Human Judgement With an Accessible, Powerful, Data-Driven Financial AI Toolkit